117 related articles for article (PubMed ID: 9564180)
1. Amyotrophic lateral sclerosis: a lesson in deficiency diseases.
Harris ED
Nutr Rev; 1998 Mar; 56(3):81-4. PubMed ID: 9564180
[TBL] [Abstract][Full Text] [Related]
2. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells.
Oh YK; Shin KS; Yuan J; Kang SJ
J Neurochem; 2008 Feb; 104(4):993-1005. PubMed ID: 18233996
[TBL] [Abstract][Full Text] [Related]
3. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
[TBL] [Abstract][Full Text] [Related]
4. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
Hayashi Y; Homma K; Ichijo H
Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
[TBL] [Abstract][Full Text] [Related]
5. Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress.
Cookson MR; Menzies FM; Manning P; Eggett CJ; Figlewicz DA; McNeil CJ; Shaw PJ
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):75-85. PubMed ID: 12215229
[TBL] [Abstract][Full Text] [Related]
6. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis.
Kaur SJ; McKeown SR; Rashid S
Gene; 2016 Feb; 577(2):109-18. PubMed ID: 26657039
[TBL] [Abstract][Full Text] [Related]
7. [Amyotrophic lateral sclerosis and superoxide dismutase--a review].
Binzer MN; Gredal O; Brøndum-Nielsen K; Andersen PM
Ugeskr Laeger; 1997 Mar; 159(11):1593-6. PubMed ID: 9092140
[TBL] [Abstract][Full Text] [Related]
8. Role of transition metals in the pathogenesis of amyotrophic lateral sclerosis.
Vonk WI; Klomp LW
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1322-8. PubMed ID: 19021549
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis.
Urushitani M; Sik A; Sakurai T; Nukina N; Takahashi R; Julien JP
Nat Neurosci; 2006 Jan; 9(1):108-18. PubMed ID: 16369483
[TBL] [Abstract][Full Text] [Related]
10. [Superoxide dismutase-1 (SOD-1) gene mutation-dependent mechanisms of neural degeneration in amyotrophic lateral sclerosis].
Iłzecka J
Neurol Neurochir Pol; 2001; 35(3):461-9. PubMed ID: 11732268
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
12. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
[TBL] [Abstract][Full Text] [Related]
13. Is ALS caused by an altered oxidative activity of mutant superoxide dismutase?
Bush AI
Nat Neurosci; 2002 Oct; 5(10):919; author reply 919-20. PubMed ID: 12352974
[No Abstract] [Full Text] [Related]
14. Amyotrophic lateral sclerosis-related mutant superoxide dismutase 1 aggregates inhibit 14-3-3-mediated cell survival by sequestration into the JUNQ compartment.
Park JH; Jang HR; Lee IY; Oh HK; Choi EJ; Rhim H; Kang S
Hum Mol Genet; 2017 Sep; 26(18):3615-3629. PubMed ID: 28666328
[TBL] [Abstract][Full Text] [Related]
15. Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions.
Kunst CB; Mezey E; Brownstein MJ; Patterson D
Nat Genet; 1997 Jan; 15(1):91-4. PubMed ID: 8988176
[TBL] [Abstract][Full Text] [Related]
16. Determinants of rapid disease progression in ALS.
Yamanaka K; Cleveland DW
Neurology; 2005 Dec; 65(12):1859-60. PubMed ID: 16380607
[No Abstract] [Full Text] [Related]
17. Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis?
Kabashi E; Valdmanis PN; Dion P; Rouleau GA
Ann Neurol; 2007 Dec; 62(6):553-9. PubMed ID: 18074357
[TBL] [Abstract][Full Text] [Related]
18. Structural instability and Cu-dependent pro-oxidant activity acquired by the apo form of mutant SOD1 associated with amyotrophic lateral sclerosis.
Kitamura F; Fujimaki N; Okita W; Hiramatsu H; Takeuchi H
Biochemistry; 2011 May; 50(20):4242-50. PubMed ID: 21506602
[TBL] [Abstract][Full Text] [Related]
19. Amyotrophic lateral sclerosis models derived from human embryonic stem cells with different superoxide dismutase 1 mutations exhibit differential drug responses.
Isobe T; Tooi N; Nakatsuji N; Aiba K
Stem Cell Res; 2015 Nov; 15(3):459-468. PubMed ID: 26413785
[TBL] [Abstract][Full Text] [Related]
20. Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons.
Lobsiger CS; Boillée S; Cleveland DW
Proc Natl Acad Sci U S A; 2007 May; 104(18):7319-26. PubMed ID: 17463094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
